Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















лечение рака печени

The cancer dairy железы now is most frequently meeting malignant новообразованием among women, with annually increasing parameters of desease [1]. Despite of the big popularity органосохраняющего treatments, his{its} application is limited to early stages of a cancer dairy железы with a tumour no more than 3 sm, absence clinically positive axillary лимфоузлов, the size dairy железы, localization of a tumour and a number{line} of other reasons [2]. The increase in number of local relapses and quite often unsatisfactory aesthetic results [3] also takes place. Also frequency of application органосохраняющего treatments depends on quality of diagnostics of early stages of disease in concrete medical institution. Therefore the basic type of radical intervention at a cancer dairy железы still is modified radical мастэктомия in updatings Маддена and a plenty of the patients who have transferred this operative мешательство, experience the significant psychological difficulties connected to loss dairy железы [4]. Подробнее...

The problem of oncological diseases is one of main for a modern society. Under forecasts the CART desease and death rate oncological diseases all over the world will increase in 2 times for the period since 1999 for 2020: with 10 up to 20 million new cases and with 6 up to 12 million registered death. Подробнее...